Insel Gruppe AG, University Hospital Bern

NCT07284511

CollaboratorPhase 2/3Recruiting2026105 people16 Dec 2025clinicaltrials.gov

NCT06653738

Phase 3Recruiting2026400 people22 Oct 2024clinicaltrials.gov

NCT06274879

Phase 2Recruiting202636 people23 Feb 2024clinicaltrials.gov

NCT06037564

Phase 4Enrolling by invitation2023210 people14 Sept 2023clinicaltrials.gov

NCT05955365

Phase 4Recruiting20233,010 people21 Jul 2023clinicaltrials.gov

NCT05738161

Phase 1Withdrawn20230 people21 Feb 2023clinicaltrials.gov

NCT05057819

Phase 4Completed202122 people27 Sept 2021clinicaltrials.gov

NCT04911660

Phase 2Completed202150 people3 Jun 2021clinicaltrials.gov

NCT04874428

Phase 1Recruiting202124 people5 May 2021clinicaltrials.gov

NCT04870424

Phase 3Completed2021120 people3 May 2021clinicaltrials.gov

NCT04516941

Phase 3Terminated202160 people18 Aug 2020clinicaltrials.gov

NCT04140968

Phase 4Terminated20192 people28 Oct 2019clinicaltrials.gov

NCT04049110

Phase 3Completed202039 people7 Aug 2019clinicaltrials.gov

NCT04035031

Phase 3Completed202013 people29 Jul 2019clinicaltrials.gov

NCT03287609

Phase 3Completed2018308 people19 Sept 2017clinicaltrials.gov

NCT03067844

Phase 3Completed2017294 people1 Mar 2017clinicaltrials.gov

NCT02918955

Phase 3Completed201665 people29 Sept 2016clinicaltrials.gov

NCT01311167

Phase 3Terminated20112 people9 Mar 2011clinicaltrials.gov

NCT01126255

Phase 2Terminated201137 people19 May 2010clinicaltrials.gov

NCT01111656

Phase 2Completed200728 people27 Apr 2010clinicaltrials.gov